IL13 Contributes to Fibrotic Progression of the Myeloproliferative Neoplasms

骨髓 骨髓纤维化 巨核细胞 纤维化 免疫学 医学 癌症研究 生物 病理 造血 干细胞 遗传学
作者
Johanna Melo‐Cardenas,Lavanya Bezavada,Jeremy Chase Crawford,Sandeep Gurbuxani,Anitria Cotton,Christian Marinaccio,John D. Crispino
出处
期刊:Blood [Elsevier BV]
卷期号:138 (Supplement 1): 60-60 被引量:1
标识
DOI:10.1182/blood-2021-151492
摘要

Abstract Pre-fibrotic-primary myelofibrosis PMF (Pre-PMF) is an indolent form of PMF that frequently progresses to overt-PMF. While both stages of the disease are characterized by the presence of dysplastic megakaryocytes, progression to fulminant disease is associated with significantly increased fibrosis in the bone marrow. We have previously shown that megakaryocyte maturation in overt-PMF is impaired due to a GATA1 deficiency. However, in Pre-PMF patients most megakaryocytes express GATA1. This raises the possibility that alterations in megakaryocyte development occur during the progression of the disease and may contribute to fibrosis. This progression in megakaryocyte defects is likely driven not only by the aberrant JAK/STAT signaling but also microenvironmental factors. To identify such factors, we performed studies in two mouse models of PMF (driven by JAK2V617 and MPLW515L mutations) before and after development of fibrosis. Using an unbiased approach, we measured the levels of different cytokines in the bone marrow, plasma, and spleen. In addition, we performed single cell RNAseq in bone marrow populations. We observed extensive changes in the level of cytokines in the bone marrow of the MPLW515L mouse model compared to the JAK2V617F model. We initially focused on those cytokines that are elevated in the bone marrow of both murine models, including IL13 (Figure 1A), because previous studies have shown that IL13 is elevated in PMF patients and that JAK2 inhibitors do not decrease IL13 (1-3). Moreover, elevated IL13 has been identified in patients who progress to secondary AML (2). How IL13 may contribute to the progression of the disease has not been investigated. We assayed the effect of IL13 on megakaryocytes in vitro and discovered that it promoted megakaryocyte differentiation in the absence of thrombopoietin (TPO) and potentiated the effect of TPO. This effect was observed in cultures of both wild-type and MPLW515L megakaryocytes. Next, we assayed for expression of the IL13 receptor (Il13ra1) in the bone marrow of JAK2V617F and MPLW515L mutant mice and found that it was highly upregulated compared to wild-type animals. IL13ra1 expression was particularly intense in the megakaryocyte lineage, and its expression increased with disease progression (Figure 1B). Next, we asked whether IL13 is essential for myeloproliferative neoplasm (MPN) development in vivo. To study this, we transplanted bone marrow cells from Il4/13 f/f Mx1-Cre mice expressing MPLW515L to irradiated recipients, waited until MPN developed, and then excised by pIpC injection. This experiment revealed that loss of IL13 and IL4 led to a profound reduction in disease burden (Figure 1C), decreased splenomegaly, and diminished degree of bone marrow fibrosis. Moreover, loss of IL13 and IL4 decreased the levels of pro-inflammatory cytokines in the bone marrow and spleen (Figure 1D). We attribute this effect to deletion of IL13 because IL4 was only moderately increased in the bone marrow of the MPLW515L mouse model, and because IL4 has been reported to not be altered in the MPNs. Finally, we performed single cell RNA-seq on bone marrow cells from mice transplanted with JAK2V617F or control progenitor cells early and late in the disease process (Figure 1E). Our results revealed that there was decreased myeloid progenitors but an enhancement in the mast cell lineage that tracked with the degree of fibrosis. We confirmed the presence of elevated numbers of mast cells in the bone marrow by immunohistochemistry (Figure 1F). Mast cells produce IL13, and therefore they are the likely source for the increased IL13. Finally, consistent with the observation that IL13 signaling is primarily mediated through STAT6, we found enrichment of STAT6 target genes in megakaryocyte progenitors from the late timepoint in our scRNAseq data (Figure 1G). In summary, our data demonstrate that IL13 is involved in the progression of PMF and that inhibition of the IL13 signaling pathway should be investigated as a therapeutic option in PMF. 1. Tefferi A, et al. J Clin Oncol (2011) 2. Fisher DAC, et al. Leukemia (2019) 3. Chen P, et al. Front Med (2021) Figure 1 Figure 1. Disclosures Crispino: Forma Therapeutics: Research Funding; Scholar Rock: Research Funding; MPN Research Foundation: Membership on an entity's Board of Directors or advisory committees; Sierra Oncology: Consultancy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
阿成完成签到,获得积分10
刚刚
Pauline完成签到 ,获得积分10
刚刚
1秒前
微笑的语芙完成签到,获得积分10
1秒前
1秒前
小背包完成签到 ,获得积分10
1秒前
水寒发布了新的文献求助10
3秒前
希望天下0贩的0应助17采纳,获得10
3秒前
yu完成签到 ,获得积分10
3秒前
钟瑞乾完成签到,获得积分10
3秒前
花痴的电灯泡完成签到,获得积分10
4秒前
虚心念桃完成签到,获得积分10
5秒前
jiaolulu发布了新的文献求助10
6秒前
zyw完成签到 ,获得积分10
6秒前
ironsilica完成签到,获得积分10
9秒前
10秒前
被动科研完成签到,获得积分10
12秒前
斗牛的番茄完成签到 ,获得积分10
13秒前
所所应助时尚俊驰采纳,获得10
13秒前
zgt01发布了新的文献求助10
17秒前
背后如彤完成签到 ,获得积分10
19秒前
20秒前
通通通完成签到,获得积分10
21秒前
李治海完成签到,获得积分10
21秒前
诸葛烤鸭完成签到,获得积分10
21秒前
君君完成签到 ,获得积分10
22秒前
long0809完成签到,获得积分10
22秒前
勤劳寒烟完成签到,获得积分10
24秒前
明亮凡梦发布了新的文献求助10
25秒前
fat完成签到,获得积分10
26秒前
26秒前
26秒前
ocean完成签到,获得积分10
27秒前
Jasper应助jiaolulu采纳,获得10
28秒前
28秒前
亚亚完成签到 ,获得积分10
29秒前
13击完成签到,获得积分10
30秒前
Lucario发布了新的文献求助10
31秒前
小龙虾完成签到,获得积分10
31秒前
和谐的映梦完成签到,获得积分10
32秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038235
求助须知:如何正确求助?哪些是违规求助? 3575992
关于积分的说明 11374009
捐赠科研通 3305760
什么是DOI,文献DOI怎么找? 1819276
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022